HSA-based anti-inflammatory therapy: A new and improved approach

Future Medicinal Chemistry

Volumn 6, Issue 2, 2014, Pages 119-121

  Liang, Hong ^a   Yang, Feng ^a   Lee, Nicole ^b   Wu, Xiaoyang ^b  

^a GUANGXI NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

anti inflammatory therapy; delivery system; human serum albumin; interactive associations of drugs

Indexed keywords

ACETYLDIFLUNISAL; ACETYLSALICYLIC ACID; ALBUMIN; ANTIINFLAMMATORY AGENT; CARBON NANOTUBE; CYCLOOXYGENASE 1; DIFLUNISAL; HUMAN SERUM ALBUMIN; OXYGENASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; BINDING AFFINITY; BINDING SITE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG PACKAGING; DRUG RELEASE; DRUG SAFETY; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; IN VIVO STUDY; INFLAMMATION; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION;

ANTI-INFLAMMATORY AGENTS; DIFLUNISAL; DRUG CARRIERS; HUMANS; INFLAMMATION; PROTEIN STRUCTURE, TERTIARY; SERUM ALBUMIN;

EID: 84893169541     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.13.195     Document Type: Review

References (20)

1. Ong CK, Lirk P, Tan CH, Seymour RA. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin. Med. Res. 5, 19-34 (2007
2. Peters T. All about Albumin: Biochemistry, Genetics, and Medical Applications. Academic Press, San Diego, CA, USA (1995
3. Neumann E, Frei E, Funk D et al. Native albumin for targeted drug delivery. Expert Opin. Drug Deliv. 7, 915-925 (2010
4. Elsadek B, Kratz F. Impact of albumin on drug delivery - new applications on the horizon. J. Control. Release 157, 4-28 (2012
5. Hannah J, Ruyle WV, Jones H et al. Discovery of diflunisal. Br. J. Clin. Pharmacol. S1, 7-13 (1977
6. Gilman AG, Rall TW, Nies AS, Taylor P. The Pharmacological Basis of Therapeutics. Pergamon Press, NY, USA (1990
7. Yang F, Ma ZY, Zhang Y et al. Human serum albumin-based design of a diflunisal prodrug. Eur. J. Pharm. Biopharm. 84, 549-554 (2013
8. Mao H, Hajduk PJ, Craig R, Bell R, Borre T, Fesik SW. Rational design of diflunisal analogues with reduced affinity for human serum albumin. J. Am. Chem. Soc. 123, 10429-10435 (2001
9. Simard JR, Zunszain PA, Ha CE et al. Locating high-Affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy. Proc. Natl Acad. Sci. USA 102, 17958-17963 (2005
10. Ghuman J, Zunszain PA, Petitpas I, Bhattacharya AA, Otagiri M, Curry S. Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 353, 38-52 (2005
11. Yang F, Bian C, Zhu L, Zhao G, Huang Z, Huang M. Effect of human serum albumin on drug metabolism: Structural evidence of esterase activity of human serum albumin. J. Struct. Biol. 157, 348-355 (2007
12. Liyasova MS, Schopfer LM, Lockridge O. Reaction of human albumin with aspirin in vitro: Mass spectrometric identification of acetylated lysines 199, 402, 519, and 545. Biochem. Pharmacol. 79, 784-791(2010
13. Kragh-Hansen U. Molecular and practical aspects of the enzymatic properties of human serum albumin and of albumin-ligand complexes. Biochim. Biophys. Acta 1830(12), 5535-5544 (2013
14. Wang Y, Yu H, Shi X, Luo Z, Lin D, Huang M. Structural mechanism of ring-opening reaction of glucose by human serum albumin. J. Biol. Chem. 288, 15980-15987 (2013
15. Kratz F. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. J. Control. Release 132, 171-183 (2008
16. Zhu L, Yang F, Chen L, Meehan EJ, Huang M. A new drug binding subsite on human serum albumin and drug-drug interaction studied by x-ray crystallography. J. Struct. Biol. 162, 40-49 (2008
17. Yang F, Lee P, Ma Z et al. Regulation of amantadine hydrochloride binding with IIA subdomain of human serum albumin by fatty acid chains. J. Pharm. Sci. 102, 84-92 (2013
18. Yang F, Yue J, Ma L et al. Interactive associations of drug-drug and drug-drug-drug with IIA subdomain of human serum albumin. Mol. Pharm. 9, 3259-3265 (2012
19. Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: From bench to bedside. Mol. Aspects Med. 33, 209-290 (2012
20. Wong BS, Yoong SL, Jagusiak A et al. Carbon nanotubes for delivery of small molecule drugs. Adv. Drug Deliv. Rev. doi:10.1016/j.addr.2013.08.005 (2013) (Epub ahead of print